Kazakhstan
will be the first country in Central Asia to provide proton therapy for cancer
patients. The only such institution in the region will be located at the
new National Oncology Research Center, it can receive up to 6,000 patients per
year. It will carry out radionuclide diagnostics and therapy as well as produce
radiopharmaceuticals. There will also be a hematology oncology center capable
of performing up to 200 bone marrow transplants annually. The second block of
the facility will be a scientific and educational center with a 140-bed
hospital, three operating theaters, and a large diagnostic clinic. The oncology
center, equipped according to the latest international standards, is to be
launched in Astana in the first half of 2024. Leading international companies
from Switzerland and the U.S. were involved in the project implementation. Construction
works are already 90 percent complete.
